For patients with isolated or essential head tremor, injection of botulinum toxin into each splenius capitis muscle on day 0 and during week 12 is more effective than placebo for reducing tremor severity, according to a study ...
Nov 9, 2023
0
0
People with social anxiety disorder who receive exposure therapy may potentially benefit from testosterone administration. This is the conclusion of research by Moniek Hutschemaekers, who will be defending her Ph.D. thesis ...
Nov 9, 2023
0
1
For patients with hand osteoarthritis and synovitis, methotrexate has a potentially clinically meaningful effect on reducing pain, with no increase in adverse events, according to a study published online Oct. 12 in The Lancet.
Nov 6, 2023
0
2
For patients with recurrent bleeding due to small-intestinal angiodysplasia (SIA), thalidomide treatment results in a reduction in bleeding, according to a study published in the Nov. 2 issue of the New England Journal of ...
Nov 2, 2023
0
1
For critically ill patients undergoing mechanical ventilation for at least three days, a three-day course of inhaled amikacin reduces the subsequent burden of ventilatory-associated pneumonia, according to a study published ...
Oct 30, 2023
0
0
For patients with moderate-to-severe prurigo nodularis, nemolizumab improves symptoms, according to a study published in the Oct. 26 issue of the New England Journal of Medicine.
Oct 27, 2023
0
0
For patients with transthyretin amyloidosis (ATTR amyloidosis), administration of an RNA interference therapeutic agent, patisiran, over 12 months results in preserved functional capacity, according to a study published in ...
Oct 27, 2023
0
0
In patients with ST-segment elevation myocardial infarction (STEMI), the traditional Chinese medicine Tongxinluo, as an adjunctive therapy to guideline-directed treatment, is associated with significantly improved clinical ...
Oct 27, 2023
0
1
For patients with polymyalgia rheumatica with relapse during tapering of glucocorticoid therapy, treatment with sarilumab, the human monoclonal antibody that binds to the interleukin-6 receptor α, is efficacious for achieving ...
Oct 5, 2023
0
1
A multisite, international phase 2 trial evaluating the investigational drug garetosmab has shown that it reduced soft-tissue flare-ups significantly and prevented new areas of abnormal bone formation in patients with fibrodysplasia ...
Sep 28, 2023
0
1
